Course curriculum

    1. Abdominal aortic aneurysm monitoring - 2Qs (January 2023)

    2. Abnormal ECG (September 2019)

    3. Abnormal PTT (November 2020)

    4. ACE inhibitor and ARB use in diabetes (July 2018)

    5. Acute Aortic dissection (January 2019)

    6. Acute hypertensive complications - 2Qs (May 2022)

    7. Acute ischemic stroke - management - 4Qs (January 2019)

    8. Acute limb ischemia - 2Qs (January 2021)

    9. Acute management of blood pressure in stroke - 2Qs (July 2020)

    10. Acute myocardial infarction - algorithm (September 2020)

    11. Amiodarone - 2Qs (May 2021)

    12. Amniotic fluid embolism (May 2019)

    13. Anemia in children - 3Qs (May 2020)

    14. Anemia of chronic disease - 2Qs (March 2021)

    15. Anemia in the elderly - 2Qs (March 2019)

    16. Ankle brachial index testing (July 2019)

    17. Anticoagulation after venous thromboembolism (May 2023)

    18. Anticoagulation and the surgical patient (January 2020)

    19. Antiplatelet therapy and acute coronary syndrome (July 2021)

    20. Aortic aneurysm - 2Qs (November 2022)

    21. Aortic dissection - 2Qs (May 2020)

    22. Aortic stenosis - 3Qs (May 2023)

    23. Apical ballooning syndrome (January 2021)

    24. Aspirin and primary prevention of cardiovascular disease - 2Qs (September 2019)

    25. Aspirin therapy (September 2023)

    26. Aspirin therapy in diabetics (September 2021)

    27. Atrial fibrillation and anticoagulation - 2Qs (March 2022)

    28. Atrial fibrillation - rate versus rhythm control (November 2020)

    29. Atrial septal defects (November 2019)

    30. Autoimmune hemolytic anemia (September 2018)

    31. Behcet's syndrome - 3Qs (May 2020)

    32. Bempedoic acid (May 2023)

    33. Beta-blockers in heart failure (May 2022)

    34. Beta-blockers - Perioperative (May 2020)

    35. Beta-blockers and cardiovascular disease - 2Qs (November 2018)

    36. Bicuspid aortic valve - 2Q (July 2021) UPDATED

    37. Bicuspid aortic valve - 3Qs (July 2019)

    38. Blood transfusion threshold (July 2018)

    39. Blunt cardiac injury (May 2019)

    40. B-type natriuretic peptide (BNP) (March 2023)

    41. Bundle branch block (July 2021)

    42. Carbon Monoxide Exposure (November 2020)

    43. Cardiac autonomic neuropathy - 2Qs (July 2021)

    44. Cardiac rehabilitation - 2Qs (March 2023)

    45. Cardiac resynchronization therapy (November 2022)

    46. Cardiac stenting - 3Qs (November 2020)

    47. Cardiogenic shock - 2Qs (July 2018)

    48. Cardiomyopathy - Hypertrophic- 3Qs (January 2020)

    49. Cardiomyopathy - overview (March 2021)

    50. Cardiomyopathy - peripartum - 2Qs (March 2022)

    51. Cardiovascular screening of student athletes - 2Q (March 2021)

    52. Carotid artery stenosis - treatment (May 2022)

    53. Carotid stenosis (November 2019)

    54. Central retinal artery occlusion (July 2019)

    55. Central sleep apnea (January 2023)

    56. Cervical adenopathy (May 2023)

    57. Chronic hypertension and pregnancy - 3Qs (March 2020)

    58. Chronic kidney disease - 2Qs (May 2022)

    59. Chronic lymphocytic leukemia (May 2023)

    60. Coffee and health (July 2021)

    61. Congenital prolonged QT syndrome - 2Qs (May 2023)

    62. Contraception and cardiovascular disease - 2Qs (May 2019)

    63. Contraception and stroke risk (May 2023)

    64. CoQ10 supplementation (September 2021)

    65. Coronary artery calcium scoring - 2Qs (November 2021)

    66. Coronary artery calcium screening (January 2020)

    67. Coronary artery disease - secondary prevention - 3Q (January 2021)

    68. Cyanotic heart disease - 4Qs (March 2020)

    69. DASH eating plan (September 2018)

    70. Daylight saving time (May 2023)

    71. Deep venous thrombosis and long distance travel (November 2019)

    72. Depression and cardiovascular disease - 2Qs (January 2022)

    73. Dietary salt and cardiovascular disease - 2Qs (May 2019)

    74. Digoxin toxicity (May 2022)

    75. Digoxin toxicity (November 2018)

    76. Dilated cardiomyopathy - 3Qs (March 2023)

    77. Dilated cardiomyopathy - 2Qs (March 2021)

    78. Drowning (September 2019)

    79. Drug-induced thrombocytopenia - 2Qs (January 2023)

    80. Drug interactions and bleeding risk - Choosing Wisely (March 2023)

    81. DVT Diagnosis - 2Qs (November 2020)

    82. ECG abnormalities and psychotropic medications - 2Qs (January 2022)

    83. Endocarditis - 5Qs (November 2020)

    84. Endocarditis prophylaxis (January 2023)

    85. Eosinophilia - 2Qs (May 2020)

    86. Erectile dysfunction and cardiovascular disease (July 2021)

    87. Erectile dysfunction - lifestyle modification (January 2023)

    88. Erectile dysfunction and lifestyle modification - 2Qs (September 2019)

    89. Evaluation of the patient with bleeding - 4Qs (January 2019)

    90. Fiber - 2Qs (November 2022)

    91. Fibrates - 2Qs (January 2022)

    92. Headache in pregnancy - 3Qs (July 2019)

    93. Heart failure - 2Qs (July 2021)

    94. Heart failure - Acute - 2Qs (July 2020)

    95. Heart failure - medical treatment - 5Qs (July 2020)

    96. Heart failure with preserved ejection fraction - 3Qs (May 2021)

    97. Heparin-induced thrombocytopenia (March 2021)

    98. Hereditary spherocytosis - 3Qs (May 2022)

    99. HIV and cardiovascular disease -2Qs (January 2020)

    100. HIV and long-term comorbidities (July 2022)

    101. Hodgkin lymphoma - Classic - 5Qs (May 2020)

    102. Hydroxyurea and sickle cell disease - 2Qs (January 2019)

    103. Hyperlipidemia - nonstatin treatment - 2Qs (November 2022) - UPDATED

    104. Hyperlipidemia - nonstatin treatment (September 2020)

    105. Hypertension in adolescents - 2Qs (September 2020)

    106. Hypertension - Gestational - 3Qs (March 2020)

    107. Hypertension in the elderly (July 2021)

    108. Hypertensive emergency - 2Qs (January 2021)

    109. Hypertriglyceridemia - 2Qs (July 2021) UPDATED

    110. Hypertriglyceridemia - 2Qs (November 2018)

    111. Immune thrombocytopenia (ITP) (September 2020)

    112. Infections and cardiovascular disease -2Qs (January 2021)

    113. Infection of cardiac implantable electronic devices - 2Qs (January 2023)

    114. Inferior vena cava filter - 2Qs (July 2022)

    115. Inferior vena cava filters - 2Qs (May 2021)

    116. Intracranial aneurysm (July 2018)

    117. Intracranial arterial stenosis (September 2018)

    118. Iron overload disorders - 3Qs (May 2021)

    119. Ischemic stroke in young adults - 2Qs (March 2021)

    120. Ischemic stroke - management - 4Qs (November 2018)

    121. Ivabradine and heart failure (July 2020)

    122. JNC-8 recommendations - 3Qs (July 2021)

    123. Kawasaki disease (May 2019)

    124. Lipid guidelines - 3Qs (May 2019)

    125. Macrocytic anemia - 5Qs (July 2019)

    126. Masked and white coat hypertension - 2Qs (July 2022)

    127. Mechanical heart valve and pregnancy - 2Qs (May 2019)

    128. Medications causing heart failure - 5Qs (November 2022)

    129. Mitral valve prolapse - 2Qs (May 2019)

    130. Myocardial infarction with nonobstructive coronary disease - 3Qs (September 2021)

    131. Myocarditis - 2Qs (March 2021)

    132. Niacin - 2Qs (November 2022)

    133. Non-lipid statin use - 2Qs (November 2021)

    134. NSAIDs and cardiovascular disease - 2Qs (January 2019)

    135. Oral contraceptives and risk of venous thromboembolism (March 2020)

    136. Patent foramen ovale - 2Qs (March 2020)

    137. Pericarditis - Acute - 2Qs (September 2018)

    138. Peripartum cardiomyopathy (March 2021)

    139. Peripheral artery disease - 2Qs (May 2022)

    140. Peripheral artery disease - 3Qs (July 2020)

    141. Polycythemia vera - 3Qs (January 2021)

    142. Postpartum eclampsia (January 2019)

    143. Postprandial hypotension - 2Qs (May 2020)

    144. Post-prandial hypotension - 2Qs (July 2021)

    145. Post-thrombotic syndrome - 2Qs (November 2021)

    146. Postural orthostatic tachycardia - 2Qs (July 2020)

    147. Postural orthostatic tachycardia syndrome (September 2019)

    148. Preeclampsia early onset - 2Qs (July 2021)

    149. Preoperative cardiac assessment - 3Qs (March 2023)

    150. Preparticipation physical exam - 2Qs (May 2022)

    151. Preventing IV catheter infection - 2Qs (January 2022)

    152. Prevention of recurrent stroke - 2Qs (November 2020)

    153. Pulmonary embolism - incidental (January 2019)

    154. Pulmonary embolism - subsegmental - 2Qs (March 2019)

    155. Pulmonary hypertension - 3Qs (March 2022)

    156. Raynaud's phenomenon - 2Qs (May 2022)

    157. Renal artery stenosis - 2Qs (January 2023)

    158. Reproductive history and CVD risk - 2Qs (March 2021)

    159. Resistant hypertension - 2Qs (September 2018)

    160. Resting tachycardia (January 2022)

    161. Resting sinus tachycardia - 2Qs (September 2021)

    162. Retinopathy of prematurity - 3Qs (January 2023)

    163. Rheumatic fever - acute - 3Qs (March 2022)

    164. Screening for hypertension (January 2023)

    165. Sickle cell disease - overview - 4Qs (March 2023)

    166. Sports and co-morbid conditions - 3Qs (January 2020)

    167. Statins and primary prevention - 2Qs (July 2019)

    168. Statin side effects - 3Qs (January 2021)

    169. Stroke risk after transient ischemic attack (March 2023)

    170. Superficial thrombophlebitis (January 2020)

    171. Syncope in adults - 4Qs (September 2020)

    172. Systolic Blood Pressure Intervention Trial (SPRINT) (November 2018)

    173. Systolic hypertension - Isolated - 2Qs (May 2020)

    174. Takotsubo cardiomyopathy - 3Qs (January 2020)

    175. Temporal arteritis (March 2019)

    176. Thoracic aortic dissection - Acute - (September 2022)

    177. Thrombocytosis (November 2018)

    178. Thrombolysis after stroke -2Qs (March 2020)

    179. Thrombotic thrombocytopenic purpura - 2Qs (September 2019)

    180. Transfusion reactions - 3Qs (March 2019)

    181. Transient ischemic attack (TIA) - 3Qs (January 2021)

    182. Understanding lipid recommendations - 2Qs (September 2018)

    183. Unprovoked venous thrombosis - 4Qs (November 2019)

    184. Varicose veins - 2Qs (September 2022)

    185. Venous thromboembolism and malignancy - 2Qs (January 2019)

    186. Ventriculoseptal defect - 2Qs (July 2021)

About this course

  • Free
  • 186 lessons
  • 0 hours of video content